Sumitomo Mitsui Trust Group Inc. Raises Stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Sumitomo Mitsui Trust Group Inc. boosted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 257,900 shares of the real estate investment trust’s stock after acquiring an additional 2,790 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.11% of Sabra Healthcare REIT worth $4,506,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. VSM Wealth Advisory LLC bought a new stake in Sabra Healthcare REIT during the fourth quarter worth approximately $26,000. UMB Bank n.a. raised its stake in shares of Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock worth $36,000 after buying an additional 1,621 shares in the last quarter. Assetmark Inc. raised its stake in shares of Sabra Healthcare REIT by 33.4% in the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock worth $45,000 after buying an additional 656 shares in the last quarter. Fifth Third Bancorp raised its stake in shares of Sabra Healthcare REIT by 110.3% in the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust’s stock worth $67,000 after buying an additional 2,011 shares in the last quarter. Finally, GF Fund Management CO. LTD. bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth $74,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of NASDAQ:SBRA opened at $18.62 on Friday. The stock has a market capitalization of $4.43 billion, a P/E ratio of 31.55, a P/E/G ratio of 1.41 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 1-year low of $15.11 and a 1-year high of $20.03. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89. The business has a 50-day moving average price of $17.91 and a two-hundred day moving average price of $17.32.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.01. The business had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. Sabra Healthcare REIT’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.35 earnings per share. Equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were paid a $0.30 dividend. The ex-dividend date was Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.45%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 203.39%.

Insider Activity at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the sale, the director owned 64,725 shares of the company’s stock, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research note on Monday, June 23rd. Truist Financial upped their price objective on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, March 18th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $19.67.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.